Page 15 - சீப்ப ஒன்றுபட்டது மாநிலங்களில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biogen s Aduhelm: US lawmakers launch investigation into FDA approval and price of new Alzheimer s drug CNN 16 hrs ago By Jacqueline Howard, CNN © Steven Senne/AP People pass the Biogen Inc., headquarters, Wednesday, March 11, 2020, in Cambridge, Mass. (AP Photo/Steven Senne) Two House committees have launched an investigation into the approval and pricing of the Alzheimer s disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm. The US Food and Drug Administration approved the drug earlier this month under its accelerated approval program, although an FDA advisory committee concluded last year that there was not enough evidence to support the effectiveness of the treatment.

United kingdomUnited statesCarolyn maloneyAaron kesselheimKristoffer tripplaar sipaTristan massieJason karlawishDominick reuterFrank pallone jrG caleb alexanderDrug administrationCentral nervous system drugs advisory committeeCommittee on oversightHarvard medical schoolOffice of neurologyBiogen inc